Cargando…
Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Activity
Pharmacologically targeting activated STAT3 and/or STAT5 has been an active area of cancer research. The cystine/glutamate antiporter, system x(c)(-), contributes to redox balance and export of intracellularly produced glutamate in response to up-regulated glutaminolysis in cancer cells. We have pre...
Autores principales: | Linher-Melville, Katja, Nashed, Mina G., Ungard, Robert G., Haftchenary, Sina, Rosa, David A., Gunning, Patrick T., Singh, Gurmit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981357/ https://www.ncbi.nlm.nih.gov/pubmed/27513743 http://dx.doi.org/10.1371/journal.pone.0161202 |
Ejemplares similares
-
xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain
por: Ungard, Robert G, et al.
Publicado: (2019) -
Inhibiting STAT3 in a murine model of human breast cancer-induced bone pain delays the onset of nociception
por: Linher-Melville, Katja, et al.
Publicado: (2019) -
The transcriptional responsiveness of LKB1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells
por: Linher-Melville, Katja, et al.
Publicado: (2014) -
Expression of xCT and activity of system x(c)(−) are regulated by NRF2 in human breast cancer cells in response to oxidative stress
por: Habib, Eric, et al.
Publicado: (2015) -
Functional effects of TrkA inhibition on system x(C)(−)-mediated glutamate release and cancer-induced bone pain
por: Miladinovic, Tanya, et al.
Publicado: (2018)